Overview

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug-drug interaction of CKD-346(Telmisartan/S-Amlodipine, Rosuvastatin)
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Amlodipine
Niacin
Rosuvastatin Calcium
Telmisartan